Evidence map›Paper›PMID 25626868›Full record

ArticlePhysiological reports2015

Direct interactions between ENaC gamma subunit and ClCN2 in cystic fibrosis epithelial cells.

Katherine R Henry, Seakwoo Lee, Douglas Walker, Pamela L Zeitlin

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Katherine R HenryDepartment of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Seakwoo LeeDepartment of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Douglas WalkerDepartment of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Pamela L ZeitlinDepartment of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

Multidisciplinary Training Program in Pediatric PulmonaryT32HL072748 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Joseph Michael Collaco · 2003 to 2026
$6.1M
CHLORIDE CHANNELS IN LUNG DEVELOPMENTR01HL059410 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ZEITLIN, PAMELA L. · 2000 to 2012
$3.8M
NHLBI NIH HHS R01 HL059410NHLBI NIH HHS T32 HL072748
6 · The paper itself

Abstract

Cystic fibrosis (CF) is a lethal disease caused by mutations in the chloride channel CFTR gene. The disease is characterized by decreased chloride secretion and unregulated sodium absorption through the epithelial sodium channel (ENaC) in the airway epithelium and other affected organs. We hypothesize that a non-CFTR alternative chloride channel ClCN2 can be activated to negatively regulate ENaC in CF epithelial cell cultures. We identified a novel interaction between ClCN2 and the ENaCγ subunit in CF airway epithelial cells and show that the upregulation of ClCN2 leads to decreased expression of ENaCγ via a K63 ubiquitination mechanism. These regulatory effects of ClCN2 on ENaCγ appear to be dependent on the CBS-1 domain located within the c-terminus of ClCN2, which is necessary for the targeting of ClCN2 to the apical surface. In sum, these results suggest the ability of ClCN2 to negatively regulate sodium absorption through ENaC, supporting its role as a therapeutic target for the treatment of CF.

Indexed as

Chloride channel N2chloride secretioncystic fibrosisepithelial sodium channelsodium absorptionubiquitination

Identifiers

PMID25626868
PMCPMC4387756
OpenAlexW2052606356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.